TRUE Private Wealth Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $6.24M | Sell |
24,787
-2,316
| -9% | -$498K | 0.54% | 35 |
|
|
2026
Q1 | $5.89M | Buy |
27,103
+11
| +0% | +$2.44K | 0.56% | 35 |
|
|
2025
Q4 | $6.19M | Buy |
27,092
+82
| +0.3% | +$18.7K | 0.62% | 32 |
|
|
2025
Q3 | $6.25M | Buy |
27,010
+384
| +1% | +$78.2K | 0.64% | 30 |
|
|
2025
Q2 | $4.94M | Sell |
26,626
-236
| -0.9% | -$43.9K | 0.56% | 31 |
|
|
2025
Q1 | $5.63M | Sell |
26,862
-1,988
| -7% | -$386K | 0.68% | 30 |
|
|
2024
Q4 | $5.13M | Sell |
28,850
-370
| -1% | -$68K | 0.62% | 27 |
|
|
2024
Q3 | $5.77M | Sell |
29,220
-323
| -1% | -$60.3K | 0.69% | 27 |
|
|
2024
Q2 | $5.07M | Sell |
29,543
-1,975
| -6% | -$327K | 0.57% | 33 |
|
|
2024
Q1 | $5.74M | Sell |
31,518
-5,910
| -16% | -$1.02M | 0.66% | 29 |
|
|
2023
Q4 | $5.8M | Buy |
37,428
+2,399
| +7% | +$350K | 0.73% | 25 |
|
|
2023
Q3 | $5.22M | Buy |
35,029
+1,572
| +5% | +$231K | 0.73% | 27 |
|
|
2023
Q2 | $4.51M | Sell |
33,457
-302
| -0.9% | -$44.3K | 0.67% | 26 |
|
|
2023
Q1 | $5.38M | Buy |
33,759
+530
| +2% | +$81K | 0.8% | 21 |
|
|
2022
Q4 | $5.37M | Buy |
33,229
+454
| +1% | +$69.6K | 0.83% | 14 |
|
|
2022
Q3 | $4.4M | Buy |
32,775
+2,936
| +10% | +$421K | 0.67% | 18 |
|
|
2022
Q2 | $4.57M | Buy |
29,839
+585
| +2% | +$89.4K | 0.66% | 20 |
|
|
2022
Q1 | $4.43M | Sell |
29,254
-8,833
| -23% | -$1.28M | 0.62% | 21 |
|
|
2021
Q4 | $5.16M | Buy |
38,087
+2,357
| +7% | +$278K | 0.73% | 20 |
|
|
2021
Q3 | $3.85M | Sell |
35,730
-612
| -2% | -$69.9K | 0.56% | 27 |
|
|
2021
Q2 | $4.09M | Buy |
36,342
+1,368
| +4% | +$154K | 0.61% | 23 |
|
|
2021
Q1 | $3.79M | Buy |
34,974
+1,410
| +4% | +$151K | 0.61% | 23 |
|
|
2020
Q4 | $3.6M | Sell |
33,564
-24
| -0.1% | -$2.31K | 0.6% | 23 |
|
|
2020
Q3 | $2.94M | Sell |
33,588
-566
| -2% | -$53.3K | 0.5% | 30 |
|
|
2020
Q2 | $3.35M | Buy |
34,154
+598
| +2% | +$52.7K | 0.61% | 27 |
|
|
2020
Q1 | $2.56M | Buy |
33,556
+28,475
| +560% | +$2.43M | 0.54% | 33 |
|
|
2019
Q4 | $449K | Sell |
5,081
-448
| -8% | -$37.2K | 0.07% | 139 |
|
|
2019
Q3 | $418K | Buy |
5,529
+1,127
| +26% | +$77.3K | 0.07% | 136 |
|
|
2019
Q2 | $320K | Sell |
4,402
-30
| -0.7% | -$2.36K | 0.05% | 152 |
|
|
2019
Q1 | $357K | Sell |
4,432
-1,749
| -28% | -$143K | 0.07% | 135 |
|
|
2018
Q4 | $569K | Sell |
6,181
-5,325
| -46% | -$468K | 0.1% | 125 |
|
|
2018
Q3 | $1.09M | Sell |
11,506
-690
| -6% | -$65.4K | 0.15% | 94 |
|
|
2018
Q2 | $1.13M | Buy |
12,196
+2,339
| +24% | +$228K | 0.18% | 87 |
|
|
2018
Q1 | $933K | Buy |
9,857
+148
| +2% | +$16.3K | 0.16% | 90 |
|
|
2017
Q4 | $939K | Buy |
9,709
+4,472
| +85% | +$421K | 0.16% | 86 |
|
|
2017
Q3 | $465K | Buy |
5,237
+423
| +9% | +$32.2K | 0.1% | 88 |
|
|
2017
Q2 | $349K | Buy |
4,814
+27
| +0.6% | +$1.81K | 0.08% | 101 |
|
|
2017
Q1 | $313K | Buy |
4,787
+24
| +0.5% | +$1.51K | 0.07% | 102 |
|
|
2016
Q4 | $290K | Buy |
4,763
+186
| +4% | +$11.4K | 0.07% | 111 |
|
|
2016
Q3 | $279K | Buy |
4,577
+13
| +0.3% | +$842 | 0.09% | 106 |
|
|
2016
Q2 | $282K | Buy |
4,564
+799
| +21% | +$48.7K | 0.09% | 100 |
|
|
2016
Q1 | $215K | Buy |
+3,765
| New | +$210K | 0.08% | 120 |
|
Other funds holding ABBV
TRUE Private Wealth Advisors's ABBV Position: Q2 2026 in Review
TRUE Private Wealth Advisors reduced its AbbVie (ABBV) stake by 8.5% in Q2 2026, selling an estimated $498K and leaving 24,787 shares worth $6.24M. The position accounts for 0.54% of the portfolio, ranked #35.
TRUE Private Wealth Advisors first reported a position in ABBV in Q1 2016 and has held it in 42 quarters since. The position peaked at $6.25M in Q3 2025. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- TRUE Private Wealth Advisors held 24,787 shares of AbbVie worth $6.24M as of Q2 2026.
- TRUE Private Wealth Advisors sold 2,316 AbbVie shares in Q2 2026, an estimated $498K.
- AbbVie made up 0.54% of TRUE Private Wealth Advisors's portfolio in Q2 2026, its #35 holding.
- TRUE Private Wealth Advisors first reported a position in AbbVie in Q1 2016 and has held it in 42 quarters since.
- TRUE Private Wealth Advisors's AbbVie position peaked at $6.25M in Q3 2025.
- 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on TRUE Private Wealth Advisors's 13F filing for Q2 2026, filed 23 Jul 2026.